John R. Mackey - Concepedia

Author

John R. Mackey

Also Known As

C. M. Halloran, Haykowsky, Mark, J Mackey, J R Mackey, J. Mackey, J. R. Mackey, J.-B Bachet, J.R. Mackey, JOHN R. MACKEY, John MacKey

562

Publications

40.6K

Citations

100

H-Index

170

Concepts

All Affiliations

University of Alberta Alberta Health Services University of British Columbia Alberta Cancer Foundation BC Cancer Agency

About

John R. Mackey is an author at University of Alberta specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	42	72	8.1K
2	Health Sciences	18	19	4.1K
3	Natural Sciences	6	6	164
4	Engineering	3	3	185
5	Arts	1	1	122

John R. Mackey

229

Publications

32.3K

Citations

H-Index

Page 1

	Year	Citations
Adjuvant Trastuzumab in HER2-Positive Breast Cancer Dennis J. Slamon, W. Eiermann, Nicholas J. Robert, New England Journal of Medicine	2011	2.7K
The clonal and mutational evolution spectrum of primary triple-negative breast cancers Sohrab P. Shah, Andrew Roth, Rodrigo Goya, Nature Breast OncologyTumor HeterogeneityMedicinePathologyCancer Genomics	2012	2K
Effects of Aerobic and Resistance Exercise in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Multicenter Randomized Controlled Trial Kerry S. Courneya, Roanne Segal, John R. Mackey, Journal of Clinical Oncology	2007	1.2K
Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment Carla M. Prado, Vickie E. Baracos, Linda J. McCargar, Clinical Cancer Research	2009	1.1K
Adjuvant Docetaxel for Node-Positive Breast Cancer Miguel Martín, Tadeusz Pieńkowski, John R. Mackey, New England Journal of Medicine	2005	950
Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial. Lee S. Rosen, David Gordon, Mary Kaminski, PubMed	2002	899
Long‐term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma Lee S. Rosen, David Gordon, Mary Kaminski, Cancer	2003	872
Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study Bella Kaufman, John R. Mackey, Michael Clemens, Journal of Clinical Oncology	2009	848
Randomized Controlled Trial of Exercise Training in Postmenopausal Breast Cancer Survivors: Cardiopulmonary and Quality of Life Outcomes Kerry S. Courneya, John R. Mackey, Gordon J. Bell, Journal of Clinical Oncology	2003	744
Metabolic Modulation of Glioblastoma with Dichloroacetate Evangelos D. Michelakis, Gopinath Sutendra, Peter Dromparis, Science Translational Medicine	2010	707

Page 1